Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BRKR
HoldHot AirBruker Corporation · Healthcare · United States · $8.7B · Avg Vol: $123M/d
COMPANY DESCRIPTION
Bruker Corporation designs, manufactures, and markets high-performance scientific instruments and solutions vital for molecular and materials research, industrial analysis, and clinical diagnostics. The company's competitive moat is established through its highly specialized and advanced instrumentation, robust R&D capabilities, and extensive patent portfolio, which fosters deeply integrated relationships within the global scientific community. Bruker is a global leader in scientific instrumentation, particularly renowned for its expertise in mass spectrometry and magnetic resonance technologies.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.5B | 3.0B | 3.4B | 3.4B | 10.7% | 3.5B | 3.6B | 3.7B | 3.8% |
| EPS | 2.00 | 2.92 | 0.76 | -0.15 | -38.4% | -0.70 | — | — | — |
| Shares | 147.0M | 145.2M | 151.7M | 152.1M | +3.5% | 152.4M | — | — | — |
| Debt | 1.3B | 1.4B | 2.2B | 2.0B | 17.2% | 1.9B | — | — | — |
| Equity | 1.1B | 1.4B | 1.8B | 2.5B | 30.4% | — | — | — | — |
| Op CF | 274.4M | 350.1M | 251.3M | 134.1M | -21.2% | 190.4M | — | — | — |
| Inv CF | -251.6M | -326.0M | -1.8B | -196.5M | — | — | — | — | — |
| Fin CF | -415.3M | -193.4M | 1.2B | 135.1M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BRKR are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BRKR | Bruker Corporation(you) | $8.7B | 47 | Hold |
| PODD | Insulet Corporation | $10.1B | 48 | Hold |
| GKOS | Glaukos Corporation | $10.6B | 46 | Hold |
| PEN | Penumbra, Inc. | $12.7B | 51 | Hold |
| NEOG | Neogen Corporation | $2.5B | 46 | Hold |
| BIO | Bio-Rad Laboratories, Inc. | $10.4B | 70 | Buy |
| IRTC | iRhythm Holdings, Inc. | $4.0B | 34 | Sell |
| BFLY | Butterfly Network, Inc. | $2.2B | 41 | Hold |
| AXGN | Axogen, Inc. | $2.8B | 57 | Hold |
| ITGR | Integer Holdings Corporation | $4.3B | 68 | Buy |
Peer medians: ROE -30.8% · P/E 27.0x · Gross margin 58.3%